Beckman Coulter, Inc. (NYSE:BEC) announced today that it has licensed certain rights to testing for the hepatitis C virus (HCV) from Siemens Healthcare Diagnostics. Under the agreement, Beckman Coulter can develop, manufacture and sell a quantitative viral load HCV blood test for use on the company’s molecular diagnostic instrument, which is in development. As a [...]

Continue reading " Beckman Coulter Acquires Rights to Hepatitis C Virus "